1477 — Ocumension Therapeutics Balance Sheet
0.000.00%
- HK$4.43bn
- HK$3.64bn
- CNY417.31m
- 21
- 17
- 43
- 13
Annual balance sheet for Ocumension Therapeutics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,052 | 1,785 | 1,314 | 1,054 | 769 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 48.6 | 44.4 | 113 | 119 | 164 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,103 | 1,835 | 1,455 | 1,206 | 979 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 82 | 366 | 448 | 468 | 452 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 2,600 | 3,331 | 3,044 | 3,271 | 3,974 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 91.9 | 216 | 248 | 315 | 155 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 97.2 | 223 | 295 | 351 | 200 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Total Equity | 2,502 | 3,108 | 2,749 | 2,920 | 3,774 |
Total Liabilities & Shareholders' Equity | 2,600 | 3,331 | 3,044 | 3,271 | 3,974 |
Total Common Shares Outstanding |